<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e> (APS) is an acquired autoimmune thrombotic tendency that is identified by the presence of abnormal antiphospholipid laboratory tests in patients who have a history of vascular <z:mp ids='MP_0005048'>thrombosis</z:mp> and/or <z:e sem="disease" ids="C0032962" disease_type="Disease or Syndrome" abbrv="">pregnancy complications</z:e> including recurrent spontaneous <z:e sem="disease" ids="C0000786" disease_type="Disease or Syndrome" abbrv="">miscarriages</z:e> and a group of other complications due to <z:mp ids='MP_0006372'>placental insufficiency</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Diagnostic testing for APS is often problematic because of many misconceptions regarding these empirically derived assays </plain></SENT>
<SENT sid="2" pm="."><plain>This chapter is intended to provide hematology-<z:hpo ids='HP_0002664'>oncology</z:hpo> consultants with practical information about the uses and limitations of assays used to diagnose APS </plain></SENT>
</text></document>